0byt3m1n1

Path: /home/artemisi/mail/.Trash/cur/ [ Home ]
File: 1628698427.M376825P22415.cp05.machighway.com,S=5112,W=5195:2,S
Envelope-to: artemisi@cp05.machighway.com
Delivery-date: Mon, 26 Aug 2019 07:00:28 -0400
Auto-Submitted: auto-replied
From: Mail Delivery System <Mailer-Daemon@cp05.machighway.com>
To: artemisi@cp05.machighway.com
Content-Type: multipart/report; report-type=delivery-status; boundary=1566817228-eximdsn-2057018190
MIME-Version: 1.0
Subject: Mail delivery failed: returning message to sender
Message-Id: <E1i2Cjc-0003IL-I9@cp05.machighway.com>
Date: Mon, 26 Aug 2019 07:00:28 -0400

--1566817228-eximdsn-2057018190
Content-type: text/plain; charset=us-ascii

This message was created automatically by mail delivery software.

A message that you sent could not be delivered to one or more of its
recipients. This is a permanent error. The following address(es) failed:

  kirtanadmin@shubalananda.com
    No Such User Here

--1566817228-eximdsn-2057018190
Content-type: message/delivery-status

Reporting-MTA: dns; cp05.machighway.com

Action: failed
Final-Recipient: rfc822;kirtanadmin@shubalananda.com
Status: 5.0.0

--1566817228-eximdsn-2057018190
Content-type: message/rfc822

Return-path: <artemisi@cp05.machighway.com>
Received: from artemisi by cp05.machighway.com with local (Exim 4.92)
	(envelope-from <artemisi@cp05.machighway.com>)
	id 1i2Cjc-0003IG-EV
	for kirtanadmin@shubalananda.com; Mon, 26 Aug 2019 07:00:28 -0400
To: kirtanadmin@shubalananda.com
Subject: [Shubalananda Kirtan] Please moderate: "Welcome to the new Shubalananda Kirtan website!"
X-PHP-Script: shubalananda.com/wp-comments-post.php for 5.188.211.22
Date: Mon, 26 Aug 2019 11:00:28 +0000
From: WordPress <wordpress@shubalananda.com>
Message-ID: <8bc39126fe018b522dc08c9e6dd42a66@shubalananda.com>
X-Mailer: PHPMailer 5.2.22 (https://github.com/PHPMailer/PHPMailer)
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit

A new comment on the post "Welcome to the new Shubalananda Kirtan website!" is waiting for your approval
http://shubalananda.com/2017/09/25/welcome-to-the-new-shubalananda-kirtan-website/

Author: Nathaniel (IP address: 5.188.211.22, 5.188.211.22)
Email: barry9e@lycos.com
URL: http://www.mundotrundle.com/vigrx-plus-ebay-uk-0ab5.pdf
Comment: 
I'm on holiday <a href="https://www.titanexteriorsnw.com/turbomedkr-8eac.pdf" rel="nofollow">buyhealth.in</a>  Marketing has been refocused on bargains and private-labellines like St. Johnâs Bay, a $1 billion brand whose womenâsapparel was discontinued under Johnson. The company is bringingback three other brands popular with older, female shoppers: thelingerie line Ambrielle, outdoor-apparel Made for Life and JCPHome.
 <a href="http://miscampinas.com.br/parceria/index.php/networkhealthconnectionscom-73d2.pdf" rel="nofollow">steroids-alternatives.space</a>  Last month the New York Post newspaper first reported thatRemini had left the church after "being subjected to years of'interrogations' and 'thought modification' for questioningleader David Miscavige's rule."
 <a href="http://www.virtualtradeshows.info/zantac-coupon-deal-7d79.pdf" rel="nofollow">how much does baby zantac cost</a>  It covers, among other things, a Â£10.5m fine imposed on it last year, as well as an expected Â£14.5m in compensation payments for the 300,000 policies it sold directly, without the help of other banks or credit card companies.
 <a href="http://shirleetemper.com/index.php/souletics-experience-a374.pdf" rel="nofollow">souletics health solutions</a>  His recollections from when he represented America in the Walker Cup at Royal Aberdeen in Scotland in 2011 may interest Tom Watson. The US lost, but Spieth was unbeaten in his three games, winning both singles and halving foursomes. &ldquo;I liked playing over there and to have everyone rooting against me was a blast,&rdquo; he said. &ldquo;It just kind of gave me a little more fire.&rdquo;
 <a href="http://buyslideburner.com/index.php/versionesfocus-medcom-46ea.pdf" rel="nofollow">www.focus-med.com</a>  The other key new lung drug is Anoro, which combines a LABA therapy with a long-acting muscarinic receptor antagonist (LAMA). It was recommended for approval by a U.S. federal advisory panel last week.

Approve it: http://shubalananda.com/wp-admin/comment.php?action=approve&c=31862#wpbody-content
Trash it: http://shubalananda.com/wp-admin/comment.php?action=trash&c=31862#wpbody-content
Spam it: http://shubalananda.com/wp-admin/comment.php?action=spam&c=31862#wpbody-content
Currently 30,851 comments are waiting for approval. Please visit the moderation panel:
http://shubalananda.com/wp-admin/edit-comments.php?comment_status=moderated#wpbody-content


--1566817228-eximdsn-2057018190--